(Press-News.org) CHAMPAIGN, Ill. — Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.
University of Illinois at Urbana-Champaign researchers have developed a cradle and app for the iPhone that uses the phone's built-in camera and processing power as a biosensor to detect toxins, proteins, bacteria, viruses and other molecules.
Having such sensitive biosensing capabilities in the field could enable on-the-spot tracking of groundwater contamination, combine the phone's GPS data with biosensing data to map the spread of pathogens, or provide immediate and inexpensive medical diagnostic tests in field clinics or contaminant checks in the food processing and distribution chain.
"We're interested in biodetection that needs to be performed outside of the laboratory," said team leader Brian Cunningham, a professor of electrical and computer engineering and of bioengineering at the U. of I. "Smartphones are making a big impact on our society – the way we get our information, the way we communicate. And they have really powerful computing capability and imaging. A lot of medical conditions might be monitored very inexpensively and non-invasively using mobile platforms like phones. They can detect molecular things, like pathogens, disease biomarkers or DNA, things that are currently only done in big diagnostic labs with lots of expense and large volumes of blood."
The wedge-shaped cradle contains a series of optical components – lenses and filters – found in much larger and more expensive laboratory devices. The cradle holds the phone's camera in alignment with the optical components.
At the heart of the biosensor is a photonic crystal. A photonic crystal is like a mirror that only reflects one wavelength of light while the rest of the spectrum passes through. When anything biological attaches to the photonic crystal – such as protein, cells, pathogens or DNA – the reflected color will shift from a shorter wavelength to a longer wavelength.
For the handheld iPhone biosensor, a normal microscope slide is coated with the photonic material. The slide is primed to react to a specific target molecule. The photonic crystal slide is inserted into a slot on the cradle and the spectrum measured. Its reflecting wavelength shows up as a black gap in the spectrum. After exposure to the test sample, the spectrum is re-measured. The degree of shift in the reflected wavelength tells the app how much of the target molecule is in the sample. See a video of the app in action at http://www.youtube.com/watch?v=Kh7MUjIYuyw.
The entire test takes only a few minutes; the app walks the user through the process step by step. Although the cradle holds only about $200 of optical components, it performs as accurately as a large $50,000 spectrophotometer in the laboratory. So now, the device is not only portable, but also affordable for fieldwork in developing nations.
In a paper published in the journal Lab on a Chip, the team demonstrated sensing of an immune system protein, but the slide could be primed for any type of biological molecule or cell type. The researchers are working to improve the manufacturing process for the iPhone cradle and are working on a cradle for Android phones as well. They hope to begin making the cradles available next year.
Cunningham's group is now collaborating with other groups across campus at the U. of I. to explore applications for the iPhone biosensor. The group recently received a grant from the National Science Foundation to expand the range of biological experiments that can be performed with the phone, in collaboration with Steven Lumetta, a professor of electrical and computer engineering and of computer science at the U. of I. They are also are also working with food science and human nutrition professor Juan Andrade to develop a fast biosensor test for iron deficiency and vitamin A deficiency in expectant mothers and children.
In addition, Cunningham's team is working on biosensing tests that could be performed in the field to detect toxins in harvested corn and soybeans, and to detect pathogens in food and water.
"It's our goal to expand the range of biological experiments that can be performed with a phone and its camera being used as a spectrometer," Cunningham said. "In our first paper, we showed the ability to use a photonic crystal biosensor, but in our NSF grant, we're creating a multi-mode biosensor. We'll use the phone and one cradle to perform four of the most widely used biosensing assays that are available."
INFORMATION:
Cunningham also is affiliated with the Institute for Genomic Biology, the Beckman Institute for Advanced Science and Technology, and the Micro and Nanotechnology Laboratory, all at the U. of I.
Editor's note: To contact Brian Cunningham, call 217-265-6291; email bcunning@illinois.edu.
The paper, "Label-free biodectetion using a smartphone," is available online.
Cradle turns smartphone into handheld biosensor
2013-05-24
ELSE PRESS RELEASES FROM THIS DATE:
Vaccine blackjack: IL-21 critical to fight against viral infections
2013-05-24
Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
The results are published in the Journal of Virology.
"Our findings highlight how IL-21 could be important in the development of antiviral vaccines," says research associate Ata Ur Rasheed Mohammed, PhD, the first author of the paper. The senior author is Rafi Ahmed, PhD, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar.
The findings could lead scientists designing ...
Scientists discover how rapamycin slows cell growth
2013-05-24
This news release is available in French. University of Montreal researchers have discovered a novel molecular mechanism that can potentially slow the progression of some cancers and other diseases of abnormal growth. In the May 23 edition of the prestigious journal Cell, scientists from the University of Montreal explain how they found that the anti-cancer and anti-proliferative drug rapamycin slows down or prevents cells from dividing.
"Cells normally monitor the availability of nutrients and will slow down or accelerate their growth and division accordingly. A ...
When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs
2013-05-24
HOUSTON - Even while being dragged to its destruction inside a cell, a cancer-promoting growth factor receptor fires away, sending signals that thwart the development of tumor-suppressing microRNAs (miRNAs) before it's dissolved, researchers reported in an early online publication at Nature.
Under conditions of oxygen starvation often encountered by tumors, the epidermal growth factor receptor (EGFR) gums up the cell's miRNA-processing machinery, an international team led by scientists at The University of Texas MD Anderson Cancer Center discovered.
"So when hypoxia ...
Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study
2013-05-24
GAINESVILLE, Fla. — An anti-cancer drug about to be tested in a clinical trial by a biomedical company in Ohio as a possible treatment for Alzheimer's disease has failed to work with the same type of brain plaques that plague Alzheimer's patients, according to results of a study by University of Florida researchers.
David Borchelt, Ph.D., a professor of neuroscience affiliated with the Evelyn F. and William L. McKnight Brain Institute of the University of Florida, emphasized the importance of verifying promising research results before investing in clinical studies or ...
Mayo Clinic genomic analysis lends insight to prostate cancer
2013-05-24
ROCHESTER, Minn. -- Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression. The findings appear online today in the journal Cancer Research.
"This is the first study to examine DNA alterations using next generation sequencing in adjacent Gleason patterns in the same tumor allowing us to correlate genomics with changes in pathology," says
John Cheville, M.D., Mayo Clinic pathologist and one of the authors on the ...
Research identifies a way to make cancer cells more responsive to chemotherapy
2013-05-24
VIDEO:
New research from Western University explains why some cancer cells don't respond to chemotherapy, and identifies a mechanism to rectify that. Dr. Shawn Li, Ph.D., explains how a protein called...
Click here for more information.
Breast cancer characterized as "triple negative" carries a poor prognosis, with limited treatment options. In some cases, chemotherapy doesn't kill the cancer cells the way it's supposed to. New research from Western University explains why ...
It's not your imagination: Memory gets muddled at menopause
2013-05-24
CLEVELAND, Ohio (May 23, 2013)—Don't doubt it when a woman harried by hot flashes says she's having a hard time remembering things. A new study published online in Menopause, the journal of The North American Menopause Society (NAMS), helps confirm with objective tests that what these women say about their memory is true.
In the past, some studies showed that hot flashes were related to memory problems, and some didn't. Other studies showed that, even though there was a relationship between hot flashes and what women said about memory problems, objective tests didn't ...
Hubble reveals the Ring Nebula's true shape
2013-05-24
The Ring Nebula's distinctive shape makes it a popular illustration for astronomy books. But new observations by NASA's Hubble Space Telescope of the glowing gas shroud around an old, dying, sun-like star reveal a new twist.
"The nebula is not like a bagel, but rather, it's like a jelly doughnut, because it's filled with material in the middle," said C. Robert O'Dell of Vanderbilt University in Nashville, Tenn. He leads a research team that used Hubble and several ground-based telescopes to obtain the best view yet of the iconic nebula. The images show a more complex ...
New insights contradict promising Alzheimer's research
2013-05-24
Approximately a year ago, the leading journal Science published an article about bexarotene as a potential Alzheimer's drug. A significant breakthrough and an important starting point for further Alzheimer's research. The research group of Bart De Strooper – Alzheimer's researcher at VIB and KU Leuven – in collaboration with the group of Rudi D'Hooge – KU Leuven – and scientists at Janssen Pharmaceutica, Beerse, also tested this candidate drug in various Alzheimer's animal test models. Their results were different, as were those of two American study groups. Therefore, ...
New microsphere-based methods for detecting HIV antibodies
2013-05-24
New Rochelle, NY, May 23, 2013—Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies and can measure even small amounts of multiple antibodies at one time. This novel multiplex immunoassay approach is described in an article in BioResearch Open Access, a peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The article is available on the BioResearch Open Access website ...